___

• 1. Liote F, Orcel P. Osteoarticular disorders of endocrine origin. Baillieres Best Pract Res Clin Rheumatol 2000; 14:251-76.
• 2. Colao A, Marzullo P, Vallone G, et al. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 1998; 83:2121-5.
• 3. Luzar MJ, Whisler RL, Hunder GG. Syndrome of inappropriate antidiuretic hormone secretion in association with temporal arteritis. J Rheumatol 1982; 9:957-60.
• 4. Cruz MW, Tendrich M, Vaisman M, Novis SA. Electroneuromyography and neuromuscular findings in 16 primary hypothyroidism patients. Arq Neuropsiquiatr 1996; 54:12-8.
• 5. Erickson AR, Enzenauer RJ, Nordstrom DM, Merenich JA. The prevalance of hypothyroidism in gout. Am J Med 1994; 97:231-4.
• 6. Gaches F, Delaire L, Nadalon S, et al. Frequency of autoimmune diseases in 218 patients with autoimmune thyroid pathologies. Rev Med Interne 1998; 19:173-9.
• 7. Delamere JP, Scott DL, Felix-Davies DD. Thyroid dysfunction and rheumatic diseases. J R Soc Med 1982; 75:102-6.
• 8. Helliwell M. Rheumatic symptoms in primary hyperparathyroidism. Postgrad Med J 1983; 59:236-40.
• 9. Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 1998; 37:895-900.
• 10. Buyon JP. Oral contraceptives in women with systemic lupus erythematosus. Ann Med Interne (Paris) 1996; 147:259-64.
• 11. Rosenbloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin North Am 1996; 25:473-83.
• 12. Eaton RP, Sibbitt WL Jr, Shah VO, et al. A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes. J Diabetes Complications 1998; 12:34-8.